BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4423987
Number of visits today
462
Number of downloads
4060642
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Tretiakova MS. Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary Modalities. Adv Anat Pathol 2022;29:131-40. [PMID: 35180736 DOI: 10.1097/PAP.0000000000000332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bersanelli M, Rebuzzi SE, Roviello G, Catalano M, Brunelli M, Rizzo M. Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma. Hum Vaccin Immunother 2023;19:2171672. [PMID: 36758960 DOI: 10.1080/21645515.2023.2171672] [Reference Citation Analysis]
2 Alhalabi O, Thouvenin J, Négrier S, Vano YA, Campedel L, Hasanov E, Bakouny Z, Hahn AW, Bilen MA, Msaouel P, Choueiri TK, Viswanathan SR, Sircar K, Albiges L, Malouf GG, Tannir NM. Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. Oncologist 2023:oyac262. [PMID: 36640141 DOI: 10.1093/oncolo/oyac262] [Reference Citation Analysis]
3 Argani P, Matoso A, Baraban EG, Epstein JI, Antonescu CR. MED15::TFE3 Renal Cell Carcinomas: Report of Two New Cases and Review of the Literature Confirming Nearly Universal Multilocular Cystic Morphology. Int J Surg Pathol 2023;:10668969221143455. [PMID: 36591911 DOI: 10.1177/10668969221143455] [Reference Citation Analysis]
4 Gama A, Sukhanova M, Choy B. Minimally invasive cytologic evaluation leading to the diagnosis of TFE3-rearranged renal cell carcinoma: A case report. Diagn Cytopathol 2022. [PMID: 35975764 DOI: 10.1002/dc.25042] [Reference Citation Analysis]
5 Kmeid M, Akgul M. TFE3 Rearrangement and Expression in Renal Cell Carcinoma. Int J Surg Pathol 2022;:10668969221108517. [PMID: 35912477 DOI: 10.1177/10668969221108517] [Reference Citation Analysis]
6 Alaghehbandan R, Siadat F, Trpkov K. What's new in the WHO 2022 classification of kidney tumours? Pathologica 2022;115:8-22. [PMID: 36645398 DOI: 10.32074/1591-951X-818] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345